A101G (p.Ala101Gly) variant of AGT (Angiotensinogen)
A101G (p.Ala101Gly) in AGT (Angiotensinogen) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes structural context.
A101G (p.Ala101Gly) variant details
- p.Ala101Gly
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- UniProt: Variant assessed as somatic; high impact.
- Structural context available